Chronic kidney disease and peritoneal dialysis
4 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSIATRIO LA PAZ
Madrid university hospital research foundation providing clinical trial sites and patient cohorts to European health consortia in infectious disease, chronic conditions, and rare diseases.
“Partner in IMPROVE-PD on peritoneal dialysis outcomes and third party in CORDIAL validating a continuous-flow peritoneal dialysis system.”
ES12 projects - UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU
Polish medical university combining paediatric health research, pharmaceutical drug delivery science, and medical device regulatory expertise across European consortia.
“Partner in IMPROVE-PD, investigating cardiovascular risk and personalised medicine for peritoneal dialysis patients.”
PL7 projects - INSTITUT DE RECERCA BIOMEDICA DE LLEIDA FUNDACIO DOCTOR PIFARRE
Spanish biomedical research foundation specialising in chronic disease management, connected care systems, and health sensor technologies.
“CONNECARE and IMPROVE-PD both address chronic disease management, with IMPROVE-PD specifically targeting peritoneal dialysis outcomes and cardiovascular risk.”
PrimaryES6 projects - NORTH BRISTOL NATIONAL HEALTH SERVICE TRUST
UK hospital trust contributing clinical trial sites, patient recruitment, and real-world health data to European research in antibiotics, diabetes, and renal medicine.
“IMPROVE-PD focuses on personalised medicine for peritoneal dialysis patients, including cardiovascular risk management and disease registries.”
UK4 projects